| ID | Name | CAS | Properties |
MW (g/mol) |
| 120-920-6 |
2,2-Dichloropropanoic acid compound with n,n-dimethylamine (1:1)
|
|
4 | 188.05 |
| 120-950-3 |
Silane, methylvinyl(oct-2-yloxy)(methylvinyl(oct-3-yloxy)silyloxy)-
|
|
4 | 414.78 |
| 121-557-9 |
Urea, 1-(2-chloroethyl)-3-(5,6,7,8-tetrahydro-2-naphthyl)-
|
|
4 | 252.75 |
| 121-628-0 |
3-Amino-3-(4-methylphenyl)propionic acid, N-dimethylaminomethylene-, methyl ester
|
|
4 | 248.33 |
| 121-822-4 |
1H-Purine-2,6-dione, 3,7-dihydro-1-methyl-
|
|
4 | 166.14 |
| 122-219-3 |
3-Hydroxy-4-methoxybenzoic acid, tert-butyldimethylsilyl ether, tert-butyldimethylsilyl ester
|
|
4 | 396.67 |
| 122-879-1 |
Trimethylsilyl 4-(2-aminophenyl)-4-oxo-2-[(trimethylsilyl)amino]butanoate
|
|
4 | 352.58 |
| 123-444-2 |
Spiro[benzofuran-3(2h),4'-piperidine]-2-one, 5-methyl-,
|
|
4 | 217.27 |
| 123-526-1 |
5-Pregnene-3«beta»,20«beta»,21-triol, methylboronate-TMS
|
|
4 | 430.50 |
| 123-652-1 |
3H-1,4-benzodiazepine-2,5-dione, 8-chloro-1,2,4,5-tetrahydro-1,4-dimethyl-
|
1018-73-1 |
4 | 238.67 |
| 123-693-6 |
2H-1,4-Benzodiazepin-2-one, 7-chloro-1,3-dihydro-1-methyl-5-phenyl-3-[(trimethylsilyl)oxy]-
|
35147-95-6 |
4 | 372.92 |
| 123-705-2 |
Benzamide, 2-chloro-n-cyanomethyl-n-(2-ethoxyethyl)-4-nitro-
|
|
4 | 311.72 |
| 123-811-4 |
1,7-Di(2,5-dimethylphenyl)-2,2,4,4,6,6-hexamethyl-1,3,5,7-tetraoxa-2,4,6-trisilaheptane
|
|
4 | 448.78 |
| 123-962-7 |
Silane, [[(3«beta»,17«beta»)-androst-5-ene-3,17-diyl]bis(oxy)]bis[(1,1-dimethylethyl)dimethyl-
|
42151-22-4 |
4 | 518.96 |
| 124-131-8 |
2-[2-Hydroxy-3-(N-methyl-2-pyrrolidinyl)propanyl]-N-methylpyrrolidine (isomer 1)
|
|
4 | 226.36 |
| 124-748-4 |
1,2,3,4-TETRAHYDROISOQUINOLINE, 6,7,8-TRIMETHOXY-1-METHYL-
|
|
4 | 237.30 |
| 124-812-2 |
Ketone, 5-amino-4-nitro-2-thienyl-3,4-dichlorophenyl
|
|
4 | 317.15 |
| 10-372-7 |
4,5,6,7-Tetrahydropyrazolo[1,5-d][1,2,4]-triazin-4-one, 2,5-dimethyl-7,7-pentamethylene
|
|
3 | 236.31 |
| 10-589-7 |
N-tert-Butyl-N,N'-bis(trifluoroacetyl)-6-methoxy-1,3,5-triazine-2,4-diamine
|
|
3 | 389.25 |
| 10-598-7 |
Pyridine, 1,1'-(1,2-phenylenedicarbonyl)bis[1,2,3,4-tetrahydro-
|
52881-76-2 |
3 | 296.36 |
| 10-755-2 |
4,5,6,7-Tetrahydropyrazolo[1,5-d][1,2,4]-triazin-4-one, 2,5,6-trimethyl-7,7-pentamethylene
|
|
3 | 250.35 |
| 10-832-6 |
7-(1H-Pyrrol-2-yloxymethyl)-2,3,5,8-tetrahydro-1H-pyrrolizin-1-ol
|
|
3 | 220.27 |
| 10-846-1 |
N-tert-Butyl-N'-acetyl-6-methoxy-1,3,5-triazine-2,4-diamine
|
|
3 | 239.27 |
| 10-948-8 |
Thiazolo[3,2-a]pyridinium, 8-hydroxy-5-methyl-, hydroxide, inner salt
|
30277-17-9 |
3 | 165.21 |
| 10-989-3 |
Tryptophan-leucine-methionine,N(«alpha»,«epsilon»)-trifluoroacetyl-N-O-permethyl derivative
|
|
3 | 614.72 |
| 11-006-2 |
Isonipecotic acid, N-(2,5-di(trifluoromethyl)benzoyl)-, octyl ester
|
|
3 | 481.48 |
| 11-152-0 |
4,5,6,7-Tetrahydropyrazolo[1,5-d][1,2,4]-triazin-4-one, 5-propyl-2,6-dimethyl
|
|
3 | 210.28 |
| 11-229-5 |
2,6-Pyridinedicarboxylic acid, 4-chlorobenzyl 2-methylhex-3-yl ester
|
|
3 | 389.87 |
| 11-390-6 |
4H-Pyrido[1,2-a]pyrimidin-4-one, 2-methyl-
|
1693-94-3 |
3 | 160.17 |
| 11-486-0 |
5-Androstene-3-«beta»,15-«beta»,16-«beta»,17-«beta»-tetrol, TMS
|
|
3 | 611.16 |
| 11-520-1 |
Semicarbazide, 4-methyl-1-(5-nitro-2-furoyl)-3-thio-,
|
|
3 | 244.23 |
| 11-637-2 |
(9E,12Z)-Tetradeca-9,12-dien-1-ol trimethylsilyl ether
|
|
3 | 282.54 |
| 11-661-5 |
Cholanic acid, 3«beta»,7«beta»,12«beta»-trihydroxy, Me-TMS
|
|
3 | 639.14 |
| 11-734-4 |
(24R)-24-ethyl-5«alpha»-cholestan-3«beta»,25-diol, TMS
|
|
3 | 577.08 |
| 11-772-2 |
2-Ethyl-5,5-dimethyl-4-acety;-1,3,4-oxadiazoline
|
|
3 | 170.21 |
| 11-858-7 |
1H-Pyrrol-1-yloxy, 3-(aminocarbonyl)-2,5-dihydro-2,2,5,5-tetramethyl-
|
3229-73-0 |
3 | 183.23 |
| 12-142-0 |
Piperazine, 2-keto-1-(3-trifluoromethylphenyl), 4-acetyl, acetoxy-M
|
|
3 | 344.29 |
| 12-155-6 |
3,3-Dimethyl-1-(4-phenylphenoxy)-1-(1,2,4-triazol-1-yl)butan-2-ol, trimethylsilyl ether
|
|
3 | 409.61 |
| 12-246-5 |
5-Ethyl-2,5-dimethyl-4-propionyl-1,3,4-oxadiazoline
|
|
3 | 184.24 |
| 12-411-1 |
Cholanic acid, 3«beta»,7«alpha»,12«beta»-trihydroxy, Me-DMES
|
|
3 | 681.22 |
| 12-455-3 |
cis-4,7,10,13,16,19-Docosahexaenoic acid, trimethylsilyl ester
|
|
3 | 400.68 |
| 12-553-4 |
1H-Pyrrolizine-7-methanol, 2,3,5,7a-tetrahydro-1-hydroxy-, (1S-cis)-
|
520-63-8 |
3 | 155.19 |
| 12-567-9 |
trans-1-Methyl-2-tert-butyl-3-(tert-butylimino)diaziridine
|
23044-57-7 |
3 | 183.29 |
| 12-569-7 |
Silane, dimethyl(dimethyl(2-bromo-4fluorophenoxy)silyloxy)(2-bromo-4-fluorophenoxy)-
|
|
3 | 512.29 |
| 12-883-8 |
L-Proline, N-trifluoroacetyl-, 2,2,3,3,3-pentafluoropropyl ester
|
|
3 | 343.17 |
| 12-903-5 |
N-(4-Methoxy-1,3-benzothiazol-2-yl)-2,2,3,3,4,4,4-heptafluorobutanamide
|
|
3 | 376.25 |
| 13-043-9 |
5'-S-Methyl-5'-thioadenosine, N,O,O'-tris(trifluoroacetyl)-
|
|
3 | 585.36 |
| 13-084-4 |
[1R-(1«alpha»,7a«beta»)]-[1-((Z)-2-Methyl-1-oxobut-2-enyloxy)-2,3,5,7a-tetrahydro-1H-pyrrolizin-7-yl]methyl ester of (Z)-2-hydroxymethylbut-2-enoic acid
|
87340-27-0 |
3 | 335.39 |
| 13-180-7 |
5«alpha»-Androstane-3«beta»,17«beta»-diol,bis-TMS
|
|
3 | 436.82 |
| 13-232-9 |
tert-Butyldimethylsilyl 2-[(3,5,6-trichloro-2-pyridyl)oxy]acetate
|
|
3 | 370.73 |
| 13-326-5 |
allo-Cholanic acid, 3«beta»,7«alpha»,12«beta»-trihydroxy, Me-TMS
|
|
3 | 639.14 |
| 13-391-3 |
2H-Furo[2,3-h]-1-benzopyran-2-one, 8,9-dihydro-8-(1-hydroxy-1-methylethyl)-, (S)-
|
3804-70-4 |
3 | 246.26 |
| 13-413-8 |
3,5-Dihydro-4-(methylimino)-4H-pyrazole, 3,3,5,5-tetramethyl-
|
72443-11-9 |
3 | 153.22 |
| 13-482-2 |
3.alpha.,5.beta.-dihydroxy-5.beta.-cholan-24-oic acid, TMS
|
|
3 | 609.13 |
| 13-534-4 |
N-(5,6-Dichloro-1,3-benzothiazol-2-yl)-2,2,3,3,4,4,4-heptafluorobutanamide
|
|
3 | 415.12 |
| 13-690-1 |
5-Cholenoic acid, 3-«beta»,12-«alpha»-dihydroxy, methyl ester, TMS
|
|
3 | 548.94 |
| 13-713-5 |
2,6-Pyridinedicarboxylic acid, 2-methylhex-3-yl neopentyl ester
|
|
3 | 335.44 |
| 13-761-2 |
3«alpha»-Hydroxy-5«alpha»-pregnan-20-one-O-methyloxime, triimethylsilyl
|
|
3 | 419.72 |
| 13-818-9 |
5«beta»-cholestane, 3«alpha»,7«beta»,12«alpha»-trihydroxy, TMS
|
|
3 | 637.21 |
| 13-921-4 |
1,3-Hexadiene, adduct with 4-methyl-1,2,4-triazolin-3,5-dione
|
|
3 | 195.22 |
| 14-128-4 |
Pyridine, 1,1'-(1,4-phenylenedicarbonyl)bis[1,2,3,4-tetrahydro-
|
|
3 | 296.37 |
| 14-269-8 |
5«beta»-Pregnane-3«alpha»,20«alpha»-diol, (3-O)-TBDMSi
|
|
3 | 434.77 |
| 14-306-6 |
5«beta»-Pregnane-3«alpha»,20«alpha»-diol, (3-O)-TBDMSi, (20-O)-TMSi
|
|
3 | 506.95 |
| 14-839-5 |
4,5,6,7-Tetrahydropyrazolo[1,5-d][1,2,4]-triazin-4-one, 2,5,6-trimethyl-7,7-tetramethylene
|
|
3 | 236.31 |
| 14-864-7 |
Silane, [(3«beta»)-cholesta-5,7-dien-3-yloxy]trimethyl-
|
2625-44-7 |
3 | 456.82 |
| 14-907-9 |
2-Amino-4,6-dihydroxypyrimidine, N,O,O'-tris(heptafluorobutyryl)-
|
|
3 | 715.17 |
| 14-988-0 |
Isonipecotic acid, N-(2,5-di(trifluoromethyl)benzoyl)-, ethyl ester
|
|
3 | 397.31 |
| 15-033-8 |
Europium, tris(2,2,6,6-tetramethyl-3,5-heptanedionato)-
|
15522-71-1 |
3 | 701.77 |
| 15-054-5 |
[1,2,4]Triazolo[1,5-a]pyrimidin-7-ol, 5-methyl-
|
2503-56-2 |
3 | 150.14 |
| 15-320-9 |
1H-Pyrrolizine-1-methanol, hexahydro-7-hydroxy-, [1S-(1«alpha»,7«alpha»,7a«beta»)]-
|
520-62-7 |
3 | 157.21 |
| 15-373-1 |
1H-Naphtho[2,1-b]pyran-1-one, 3-phenyl-
|
6051-87-2 |
3 | 272.30 |
| 15-609-9 |
Isonipecotic acid, N-(2,4,5-trifluoro-3-methoxybenzoyl)-, hexyl ester
|
|
3 | 401.42 |
| 15-689-1 |
4,12-Dipropyl-4,7,7,9,9,12-hexamethyl-8-oxa-4,7,9,12-tetrasilapentadecane
|
|
3 | 447.02 |
| 15-696-3 |
3«alpha»,16«alpha»-dihydroxy-5«alpha»-androstan-17-one, TMS
|
|
3 | 450.80 |
| 15-806-0 |
5-Methyl-2H-pyrazole-3-carboxylic acid, 1-methyl-2-isopropenyl hydrazide
|
|
3 | 194.23 |
| 16-093-1 |
Isonipecotic acid, N-(2,5-di(trifluoromethyl)benzoyl)-, propyl ester
|
|
3 | 411.34 |
| 16-211-9 |
1-(4-Methylphenyl)butan-1-one, O-(tert-butyldimethylsilyl)oxime
|
|
3 | 291.50 |
| 16-363-1 |
1,1,3,3-Tetramethyl-1,3-(di-3-chlorpropyl)-disiloxane
|
|
3 | 287.37 |
| 16-398-3 |
1H-pyrido[3,4-b]indole-3-carboxylic acid, 2,3,4,9-tetrahydro-
|
|
3 | 216.24 |
| 16-407-2 |
Benzofuran-2,3-dione, 2-[O-(2-acetoxyethyl)oxime], 3-(O-methyloxime), isomer 2
|
|
3 | 278.26 |
| 16-587-3 |
4H-Pyrido[1,2-a]pyrimidin-4-one, 5,6-trimethyleno, 6-methyl
|
|
3 | 200.24 |
| 16-756-5 |
5«beta»-Homocholane-3«alpha»,7«alpha»,25-triol, TMS
|
|
3 | 609.16 |
| 16-837-5 |
2,8,9-Trioxa-5-aza-1-silabicyclo[3.3.3]undecane, 1-phenyl-
|
2097-19-0 |
3 | 251.35 |
| 17-014-7 |
epi-5«beta»-Stigmastanol (24«beta»-ethyl-5«beta»-cholestan-3«alpha»-ol), TMS
|
|
3 | 488.90 |
| 17-118-2 |
24-Nor-3«alpha»,7«beta»-dihydroxy-5«beta»-cholanoic acid, MeTMS
|
|
3 | 536.93 |
| 17-121-8 |
6,7,8,9,10,11-Hexahydro-4a,12-diaza-cycloocta[b]naphthalen-5-one
|
|
3 | 228.29 |
| 17-174-0 |
4-Quinolinol, 4-ethenyldecahydro-1,2-dimethyl-, (2«alpha»,4«alpha»,4a«alpha»,8a«beta»)-
|
20431-93-0 |
3 | 209.33 |
| 17-211-8 |
Spirocyclopentane-2-(1,5,6-triazabicyclo[3.1.0]hexane), 4,4,6-tris(trifluoromethyl)-
|
|
3 | 343.19 |
| 17-274-9 |
6H-Pyrazolo[1,2-a][1,2,4,5]tetrazine, hexahydro-2,3-dimethyl-
|
70517-50-9 |
3 | 156.23 |
| 17-301-8 |
2,6-Pyridinedicarboxylic acid, 2-methylhex-3-yl 2,4,4-trimethylpentyl ester
|
|
3 | 377.52 |
| 17-642-0 |
1-(2-Methylbutoxy)-7-pentyl-2,2,4,4,6,6-hexamethyl-1,3,5,7-tetraoxa-2,4,6-trisilaheptane
|
|
3 | 380.74 |
| 17-661-9 |
N-(4-Methoxy-1,3-benzothiazol-2-yl)-N-(2,2,3,3,3-pentafluoropropanoyl)-2,2,3,3,3-pentafluoropropanamide
|
|
3 | 472.26 |
| 17-969-8 |
Isonipecotic acid, N-(2,5-di(trifluoromethyl)benzoyl)-, tetradecyl ester
|
|
3 | 565.64 |
| 18-152-3 |
4H-Pyrido[1,2-a]pyrimidin-4-one, 3-methyl
|
|
3 | 160.18 |
| 18-213-5 |
2-O-acetyl-8,12-epoxygermacra-1(10),4,7,11-tetraene, isomer I
|
|
3 | 274.35 |
| 18-430-4 |
5-Quinolinesulfonic acid, 8-hydroxy-7-(6-sulfo-2-naphthylazo)-
|
56990-57-9 |
3 | 459.45 |
| 18-481-8 |
Benzeneacetic acid, «alpha»-hydroxy-«alpha»-phenyl-, 1-methyl-3-piperidinyl ester
|
3321-80-0 |
3 | 325.40 |
| 18-495-3 |
Isonipecotic acid, N-(2,6-difluoro-3-methylbenzoyl)-, butyl ester
|
|
3 | 339.38 |
| 18-772-5 |
Benzenamine, N-[3-phenyl-4,5-bis[(trifluoromethyl)imino]-2-thiazolidinylidene]-
|
37893-02-0 |
3 | 416.34 |
| 18-921-9 |
7,8,9,10-Tetrahydro-6H-cyclohepta[d]pyrido[1,2-a]pyrimidin-11-one
|
|
3 | 234.34 |
|
« Previous Results
Next Results »
|